-
公开(公告)号:EP1414967A2
公开(公告)日:2004-05-06
申请号:EP02751257.3
申请日:2002-06-17
发明人: BEN ACHOUR, Yosser , CHENIK, Mehdi , LOUZIR, Hechmi , DELLAGI, Koussay,Institut Pasteur de Tunis
IPC分类号: C12N15/30 , C12N9/90 , C07K14/44 , G01N33/50 , G01N33/569 , G01N33/573 , C07K16/40 , C07K16/20 , C12Q1/68
CPC分类号: C12N9/90 , A61K2039/523 , A61K2039/57 , C07K2319/00 , Y02A50/41
摘要: The invention relates to the field of combating leishmaniases. Said invention results from the isolation, from wild isolates of Leishmania major, of a protein-coding gene known as LmPDI which has two regions that are identical to the sequence (Cys-Gly-His-Cys) of the potential active site of the protein disulphide isomerases (PDI). The LmPDI protein is predominantly expressed in the most virulent isolates of the parasite. Said protein forms a novel therapeutic target for developing anti-leishmaniasis medicaments and a novel element that can be used in the composition of immunogenic, and possibly vaccinating, preparations which are intended to protect a human or animal host against Leishmania.